NNVC Stock Summary and Trading Ideas (Nanoviricides | AMEX:NNVC)

Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company is engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific antiviral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing. The Company's platform is based on host-mimicry and thereby has uniquely enabled the development of broad-spectrum antiviral drugs that the viruses would be unable to escape, a critical unmet need in antiviral therapeutics.

Nanoviricides trades on the AMEX stock market under the symbol NNVC.

As of October 9, 2026, NNVC stock price declined to $1.30 with 159,882 million shares trading.

NNVC has a beta of 2.28, meaning it tends to be more sensitive to market movements. NNVC has a correlation of 0.10 to the broad based SPY ETF.

NNVC has a market cap of $33.19 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, NNVC traded as high as $3.59 and as low as $.85.

The top ETF exchange traded funds that NNVC belongs to (by Net Assets): VTI, VXF, BUSM.

NNVC has underperformed the market in the last year with a price return of -8.8% while the SPY ETF gained +17.1%. NNVC has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -19.3% and -9.7%, respectively, while the SPY returned +3.8% and +0.9%, respectively.

NNVC support price is $1.21 and resistance is $1.41 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NNVC shares will trade within this expected range on the day.